LIZA RODRIGUEZ: Open Payments
NPI 1356591028 · KANSAS CITY, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,867 in 44 payments from 11 companies in 2025. Trend: 2023 $594 · 2024 $846 · 2025 $9,867
Consulting: $5,945Travel & lodging: $2,341Food & beverage: $1,482Education: $100
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 30 | $8,828 |
| SANOFI-AVENTIS U.S. LLC | 4 | $304 |
| SOBI, INC | 1 | $131 |
| Astellas Pharma US Inc | 1 | $127 |
| Genmab U.S., Inc. | 1 | $124 |
| Janssen Biotech, Inc. | 1 | $119 |
| Celgene Corporation | 1 | $102 |
| ABBVIE INC. | 2 | $67 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Syndax Pharmaceuticals, Inc. | 1 | $20 |
Products named: REZUROCK, Gamifant, Cresemba, RYBREVANT, BREYANZI, EPKINLY, LYNOZYFIC, LONSURF.
Industry payments across KS — which companies pay providers there.
